Final results for the year to December 2019 have been largely superseded by several trading updates, the consolidation of the remaining stake in Irisium, and last week’s £1.2m net placing at 30p. Nevertheless FY19, the first full year for execution of KRM22’s risk management solutions platform in the capital markets, saw net organic ARR growth of 21%, and a further £0.5m acquired with the acquisition of Object+. Six new partnerships and the March 2019 launch of the Glo
21 May 2020
KRM22 - Finals to December 2019
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
KRM22 - Finals to December 2019
KRM22 Plc (KRM:LON) | 27.5 0 0.0% | Mkt Cap: 9.85m
- Published:
21 May 2020 -
Author:
Andrew Darley | Cavendish Research -
Pages:
11
Final results for the year to December 2019 have been largely superseded by several trading updates, the consolidation of the remaining stake in Irisium, and last week’s £1.2m net placing at 30p. Nevertheless FY19, the first full year for execution of KRM22’s risk management solutions platform in the capital markets, saw net organic ARR growth of 21%, and a further £0.5m acquired with the acquisition of Object+. Six new partnerships and the March 2019 launch of the Glo